Jefferies Financial Group Portfolio holdings
Jefferies Financial Group is the investment banking and capital markets company that was known as Leucadia National until 2018, when it took the name of the bank it merged with in 2013. Leucadia traces back to Ian Cumming and Joseph Steinberg, Harvard Business School graduates who started out at the investment bank Carl Marks & Company and in 1979 took control of Talcott National, renaming it Leucadia the next year. As a holding company it bought and resold businesses, such as the insurer Colonial Penn, acquired in 1991 and sold in two pieces in 1997, and the telecoms company WilTel, acquired in 2003 and sold in 2005. Jefferies itself grew from a small equities trading shop into a full-service investment bank, and Richard Handler became chief executive of the combined company in 2013.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$204M |
| 2 |
SPDR Gold Trust
GLD
|
+$94.6M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$88.3M |
| 4 |
Intel
INTC
|
+$58.2M |
| 5 |
Boeing
BA
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$640M |
| 2 |
Apple
AAPL
|
+$234M |
| 3 |
Meta Platforms (Facebook)
META
|
+$128M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$114M |
| 5 |
PTC Therapeutics
PTCT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.53% |
| 2 | Healthcare | 11.13% |
| 3 | Technology | 8.29% |
| 4 | Industrials | 4.73% |
| 5 | Financials | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
CALL
CleanSpark
CLSK
$1.69B
| $19M | 0.14% |
1,477,400
+1,308,200
| +773% | +$17.1M |
2025 Q1
6 quarters
|
|
127
Mondelez International
MDLZ
$84.2B
| $19M | 0.14% |
328,016
-32,388
| -9% | -$1.99M |
2025 Q3
4 quarters
|
|
128
Ventas
VTR
$47.8B
| $18.8M | 0.14% |
220,710
+206,280
| +1,430% | +$18.9M |
2026 Q2
1 quarter
|
|
129
CALL
Target
TGT
$73.5B
| $18.6M | 0.14% |
118,500
| – | – |
2026 Q1
2 quarters
|
|
130
State Street Industrial Select Sector SPDR ETF
XLI
$30.9B
| $18.5M | 0.14% |
111,031
-7,325
| -6% | -$1.3M |
2022 Q4
15 quarters
|
|
131
Genesis Energy
GEL
$1.59B
| $18.2M | 0.13% |
1,322,343
-119,015
| -8% | -$1.81M |
2024 Q2
9 quarters
|
|
132
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.74B
| $18M | 0.13% |
259,600
+30,300
| +13% | +$2.27M |
2024 Q1
10 quarters
|
|
133
CALL
TechnipFMC
FTI
$25.1B
| $17.8M | 0.13% |
262,500
+137,500
| +110% | +$10.1M |
2026 Q2
1 quarter
|
|
134
CALL
Freeport-McMoran
FCX
$86.5B
| $17.7M | 0.13% |
252,800
+147,800
| +141% | +$10.1M |
2025 Q3
4 quarters
|
|
135
DELISTED
Kenvue
KVUE
| $17.7M | 0.13% |
1,000,000
-400,048
| -29% | -$7.53M |
2025 Q4
3 quarters
|
|
136
Chime Financial
CHYM
$12.5B
| $17.5M | 0.13% |
655,280
+610,244
| +1,355% | +$16.9M |
2026 Q2
1 quarter
|
|
137
ResMed
RMD
$32.9B
| $16.9M | 0.13% |
76,568
-27,265
| -26% | -$5.95M |
2024 Q1
10 quarters
|
|
138
Abivax
ABVX
$7.88B
| $16.7M | 0.12% |
168,705
+163,934
| +3,436% | +$19.8M |
2025 Q3
4 quarters
|
|
139
PUT
iShares Russell 2000 ETF
IWM
$77.9B
| $16.7M | 0.12% |
60,000
-215,000
| -78% | -$63.1M |
2022 Q4
15 quarters
|
|
140
CRH
CRH
$64.4B
| $16.6M | 0.12% |
200,000
-202,791
| -50% | -$19.4M |
2023 Q3
12 quarters
|
|
141
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $16.4M | 0.12% |
416,900
+316,600
| +316% | +$13.8M |
2026 Q2
1 quarter
|
|
142
Semtech
SMTC
$10.6B
| $16.3M | 0.12% |
91,288
+82,687
| +961% | +$11.7M |
2026 Q1
2 quarters
|
|
|
143
PUT
Apple
AAPL
$5.06T
| $16.2M | 0.12% |
48,700
-23,200
| -32% | -$7.45M |
2024 Q2
9 quarters
|
|
144
Capital One
COF
$118B
| $16M | 0.12% |
82,970
+65,314
| +370% | +$13.7M |
2023 Q1
14 quarters
|
|
145
Tango Therapeutics
TNGX
$4.12B
| $15.7M | 0.12% |
627,609
-1,382,925
| -69% | -$36M |
2026 Q2
1 quarter
|
|
146
PUT
UBS Group
UBS
$149B
| $15.4M | 0.11% |
+320,000
| New | +$16.8M |
2026 Q3
0 quarters
|
|
147
Regeneron Pharmaceuticals
REGN
$94.8B
| $15.4M | 0.11% |
20,300
+560
| +3% | +$423K |
2025 Q3
4 quarters
|
|
148
CALL
Broadcom
AVGO
$1.58T
| $15.1M | 0.11% |
+43,000
| New | +$16.2M |
2026 Q3
0 quarters
|
|
149
PUT
iShares Bitcoin Trust
IBIT
$59.1B
| $15M | 0.11% |
317,500
-100,000
| -24% | -$4.03M |
2025 Q2
5 quarters
|
|
150
PUT
Advanced Micro Devices
AMD
$845B
| $14.9M | 0.11% |
+24,400
| New | +$12.6M |
2026 Q3
0 quarters
|
|
Similar funds
Jefferies Financial Group's Q3 2026 Portfolio in Review
As of Q3 2026, Jefferies Financial Group held 1,968 positions worth $13.5B, down 11% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jefferies Financial Group withdrew a net $3.53B in Q3 2026, closing 703 positions and reducing 401 holdings. Its most notable exit was PTC Therapeutics, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jefferies Financial Group opened a new position in Emcor worth $40.1M.
- Jefferies Financial Group's largest Q3 2026 buy was Emcor: 53,175 shares worth $40.1M.
- Jefferies Financial Group added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2026, an estimated $204M increase.
- Jefferies Financial Group's biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $640M.
- Jefferies Financial Group fully exited PTC Therapeutics in Q3 2026, selling an estimated $111M.
- Jefferies Financial Group's ten largest holdings make up 34% of its $13.5B portfolio in Q3 2026.
- Jefferies Financial Group opened 337 new positions and closed 703 in Q3 2026.
- Jefferies Financial Group's portfolio value fell 11% quarter-over-quarter to $13.5B.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.